Pharma & Biotech

The pharmaceutical sector has reached an unprecedented milestone as Eli Lilly becomes the first drugmaker to achieve a $1 trillion...

The investment case for Ocugen is under severe pressure as its stock experiences a dramatic downward spiral. With bearish investors...

Pharmaceutical titan Pfizer is aggressively reshaping its identity beyond being perceived as a pandemic beneficiary, making a substantial strategic commitment...

Despite posting impressive double-digit revenue growth and receiving votes of confidence from its leadership, Redcare Pharmacy's stock continues its relentless...

BioNxt Solutions has achieved a pivotal regulatory milestone that could fundamentally reshape its long-term commercial prospects. The biotechnology firm has...

Despite recent market jitters affecting investor sentiment, the underlying financial performance of French vaccine specialist Valneva tells a different story....

BioAtla Inc has successfully secured fresh capital, but the terms of the financing have raised significant questions about the company's...

Castle Biosciences, a prominent player in the diagnostic sector, is witnessing a remarkable surge in its stock value, with shares...

After experiencing significant pressure earlier this year, biotechnology firm Xencor is demonstrating a notable resurgence. The company's equity has advanced...

Speculative investors in InnoCan Pharma received the news they've been anticipating, with groundbreaking research data potentially paving the way for...